132 related articles for article (PubMed ID: 37327280)
21. A systematic review and meta-analysis of prospective studies on obesity and risk of inflammatory bowel disease.
Milajerdi A; Abbasi F; Esmaillzadeh A
Nutr Rev; 2022 Feb; 80(3):479-487. PubMed ID: 34157115
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.
Chen Y; Wang X
Brain Behav; 2021 Jun; 11(6):e02159. PubMed ID: 33960728
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for developing renal stones in inflammatory bowel disease.
McConnell N; Campbell S; Gillanders I; Rolton H; Danesh B
BJU Int; 2002 Jun; 89(9):835-41. PubMed ID: 12010224
[TBL] [Abstract][Full Text] [Related]
24. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
Zou ZY; Shen B; Fan JG
Inflamm Bowel Dis; 2019 Oct; 25(11):1764-1772. PubMed ID: 30918952
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory polyps occur more frequently in inflammatory bowel disease than other colitis patients.
Ashktorab H; Brim H; Hassan S; Nouraie M; Gebreselassie A; Laiyemo AO; Kibreab A; Aduli F; Latella G; Brant SR; Sherif Z; Habtezion A
BMC Gastroenterol; 2020 Jun; 20(1):170. PubMed ID: 32503428
[TBL] [Abstract][Full Text] [Related]
26. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
Kumar R; Ghoshal UC; Singh G; Mittal RD
J Gastroenterol Hepatol; 2004 Dec; 19(12):1403-9. PubMed ID: 15610315
[TBL] [Abstract][Full Text] [Related]
27. Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.
Mann S; Jess T; Allin K; Elmahdi R
Clin Transl Gastroenterol; 2022 Jul; 13(7):e00513. PubMed ID: 35905421
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.
Abdulla M; Mohammed N; AlQamish J; Mosli M
Sci Rep; 2022 Dec; 12(1):21333. PubMed ID: 36494448
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study.
Losurdo G; La Fortezza RF; Iannone A; Contaldo A; Barone M; Ierardi E; Di Leo A; Principi M
World J Gastroenterol; 2020 Dec; 26(47):7528-7537. PubMed ID: 33384552
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of Helicobacter pylori gastritis in newly diagnosed children with inflammatory bowel disease.
Roka K; Roubani A; Stefanaki K; Panayotou I; Roma E; Chouliaras G
Helicobacter; 2014 Oct; 19(5):400-5. PubMed ID: 24827117
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
[TBL] [Abstract][Full Text] [Related]
32. Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease.
Kärnsund S; Lo B; Bendtsen F; Holm J; Burisch J
World J Gastroenterol; 2020 Sep; 26(35):5362-5374. PubMed ID: 32994694
[TBL] [Abstract][Full Text] [Related]
33. The risk of dementia in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Zhang MN; Shi YD; Jiang HY
Int J Colorectal Dis; 2022 Apr; 37(4):769-775. PubMed ID: 35325272
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory bowel disease increases the levels of albuminuria and the risk of urolithiasis: a two-sample Mendelian randomization study.
Wu H; Liu P; Gong S; Liu X; Hill MA; Liu Z; Xu M; Xu C
Eur J Med Res; 2023 May; 28(1):167. PubMed ID: 37173785
[TBL] [Abstract][Full Text] [Related]
35. Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study.
Lee J; Im JP; Han K; Park S; Soh H; Choi K; Kim J; Chun J; Kim JS
World J Gastroenterol; 2019 Nov; 25(42):6354-6364. PubMed ID: 31754295
[TBL] [Abstract][Full Text] [Related]
36. Use of histamine-2 receptor antagonists and risk of inflammatory bowel diseases: A systematic review and meta-analysis of observational studies.
D'sa FF; Fernandes EZ; Kesarkar SV; Swaminathan L; Kunhikatta V; Rashid M; Thunga G; Chandran VP; Nair S
J Clin Pharm Ther; 2022 Aug; 47(8):1103-1111. PubMed ID: 35403222
[TBL] [Abstract][Full Text] [Related]
37. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and clinical features of patients with autoimmune pancreatitis and inflammatory bowel disease: A systematic review and meta-analysis.
Fukuda S; Akiyama S; Tarakji A; Hamdeh S; Suzuki H; Tsuchiya K
J Gastroenterol Hepatol; 2022 Aug; 37(8):1474-1484. PubMed ID: 35596263
[TBL] [Abstract][Full Text] [Related]
39. Renal stone formation in patients with inflammatory bowel disease.
Caudarella R; Rizzoli E; Pironi L; Malavolta N; Martelli G; Poggioli G; Gozzetti G; Miglioli M
Scanning Microsc; 1993 Mar; 7(1):371-9; discussion 379-80. PubMed ID: 8316806
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
